Jingpei Li

Dr. Jingpei Li

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2022 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
JLJun Liu
Jun Liu
JLJingpei Li
Jingpei Li
WLWanli Lin
Wanli Lin
DSDi Shao
Di Shao
LDLieven Depypere
Lieven Depypere
JHJianxing He
Jianxing He

1 March 2020 in Toxicology Letters
Verified
Journal Article
Closed access
JLJingpei Li
Jingpei Li
MFMingxiang Feng
Mingxiang Feng
RSRuiting Sun
Ruiting Sun
ZLZhuoyi Li
Zhuoyi Li
LHLei Hu
Lei Hu
JLJun Liu
Jun Liu

24 July 2020 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
JLJingpei Li
Jingpei Li
JLJun Liu
Jun Liu
WYWeifeng Yue
Weifeng Yue
KXKe Xu
Ke Xu
WCWeipeng Cai
Weipeng Cai
JHJianxing He
Jianxing He
Andrographolide (Andro), a component from Chinese medicinal herb Andrographis paniculata, could alleviate pulmonary fibrosis in rodents. Yet, whether and how Andro mitigates epithelial‐mesenchymal transition (EMT) induced by TGF‐β1 remain unknown. This study aimed to explore the effect of Andro on TGF‐β1‐induced EMT in human alveolar epithelial cells (AECs) and the mechanisms involved. We illustrated that Andro inhibited TGF‐β1‐induced EMT and EMT‐related transcription factors in alveolar epithelial A549 cells. Andro also reduced TGF‐β1‐induced cell migration and synthesis of pro‐fibrotic factors (ie CCN‐2, TGF‐β1), matrix metalloproteinases (ie MMP‐2, MMP‐9) and extracellular matrix (ECM) components (ie collagen 1), implying the inhibiting effect of Andro on TGF‐β1‐induced EMT‐like cell behaviours. Mechanistically, Andro treatment not only repressed TGF‐β1‐induced Smad2/3 phosphorylation and Smad4 nuclear translocation, but also suppressed TGF‐β1‐induced Erk1/2 phosphorylation and nuclear translocation in A549 cells. And treatment with ALK5 inhibitor (SB431542) or Erk1/2 inhibitors (SCH772984 and PD98059) remarkably reduced EMT evoked by TGF‐β1. In addition, Andro also reduced TGF‐β1‐induced intracellular ROS generation and NOX4 expression, and elevated antioxidant superoxide dismutase 2 (SOD2) expression, demonstrating the inhibiting effect of Andro on TGF‐β1‐induced oxidative stress, which is closely linked to EMT. Furthermore, Andro remarkably attenuated TGF‐β1‐induced down‐regulation of sirtuin1 (Sirt1) and forkhead box O3 (FOXO3), implying that Andro protects AECs from EMT partially by activating Sirt1/FOXO3‐mediated anti‐oxidative stress pathway. In conclusion, Andro represses TGF‐β1‐induced EMT in AECs by suppressing Smad2/3 and Erk1/2 signalling pathways and is also closely linked to the activation of sirt1/FOXO3‐mediated anti‐oxidative stress pathway.

1 October 2013
Verified
Open access
PDF file
JLJingpei Li
Jingpei Li
XCXiaoke Chen
Xiaoke Chen
YSYaxing Shen
Yaxing Shen
YHYingyong Hou
Yingyong Hou
SZShumin Zhang
Shumin Zhang
ZZZhaochong Zheng
Zhaochong Zheng
A rare collision tumor of squamous carcinoma and small cell carcinoma in esophagus involved with separate lymph nodes: a case report

1 April 2021 in Translational Lung Cancer Research
Verified
Journal Article
Open access
PDF file
YZYuan Zeng
Yuan Zeng
NMNicholas Mayne
Nicholas Mayne
CYChi-Fu J. Yang
Chi-Fu J. Yang
JLJun Liu
Jun Liu
FCFei Cui
Fei Cui
JHJianxing He
Jianxing He
Background: Chemotherapy is a common treatment for patients with resected non-small cell lung cancer (NSCLC). However, there are few models for predicting the survival outcomes of these patients. Here, we developed a clinical nomogram for predicting overall survival (OS) in this cohort. Methods: A total of 16,661 patients with resected NSCLC treated with chemotherapy were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. We identified prognostic factors and integrated them into a nomogram. The model was subjected to bootstrap internal validation using the SEER database and external validation using a database in China and the National Cancer Database (NCDB). The model’s predictive accuracy and discriminative ability were tested by calibration and concordance index (C-index). Results: Age, sex, number of dissected lymph nodes, extent of surgery, N stage, T stage, and grade were independent factors for OS and were integrated into the model. The calibration curves for probability of 1-, 3-, and 5-year OS showed excellent agreement between the predicted and actual survivals. The C-index of the nomogram was higher than that of the Tumor-Node-Metastasis staging system for predicting OS (training cohort, 0.62 vs. 0.58; China cohort, 0.68 vs. 0.63; NCDB cohort, 0.59 vs. 0.57). Conclusions: We developed a nomogram that can present individual prediction of OS for patients with resected NSCLC who are undergoing chemotherapy. This practical prognostic tool may help clinicians in treatment planning.

3 August 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
RGRuijuan Guan
Ruijuan Guan
LYLiang Yuan
Liang Yuan
JLJingpei Li
Jingpei Li
SPSee Pdf
See Pdf
Endoplasmic reticulum (ER) stress and mitochondrial dysfunction drive alveolar type II (AT2) cell apoptosis and necroptosis, which are central to the pathogenesis of idiopathic pulmonary fibrosis (IPF). Although mucin 1 (MUC1) is known to exert anti-inflammatory effects in the airways, its direct role in AT2 cells during pulmonary fibrosis remains unclear. Here, we show that MUC1 expression was specifically and significantly upregulated in AT2 cells from IPF patients and bleomycin (BLM)-induced fibrotic mice, and this upregulation correlated with disease severity. AT2 cell specific Muc1 knockout attenuated BLM-induced pulmonary fibrosis, reduced AT2 cell apoptosis and necroptosis, and alleviated ER stress and mitochondrial dysfunction in vivo. Consistently, silencing MUC1 in human A549 AT2-like cells suppressed BLM-triggered ER stress, mitochondrial dysfunction, apoptosis, and necroptosis. Mechanistically, hypoxia-inducible factor (HIF)-1α was identified as a major MUC1-interacting partner, with its protein levels significantly decreased upon MUC1 inhibition in both in vivo and in vitro models of pulmonary fibrosis. Co-immunoprecipitation and docking analyses revealed that MUC1 directly interacts with HIF-1α via key residues including PHE1148 and TYR1212, and MUC1 knockdown decreased HIF-1α protein levels in A549 cells. HIF-1α overexpression reversed the protective effects of MUC1 silencing on BLM-induced ER stress, mitochondrial dysfunction, apoptosis, and necroptosis in A549 cells. Consistently, HIF-1α activation abolished the anti-fibrotic benefits of AT2-specific Muc1 deletion in mice, reversing the attenuation of ER stress and mitochondrial dysfunction observed following BLM injury. Furthermore, adeno-associated virus 9 (AAV9)-mediated AT2-specific Muc1 knockdown reversed established lung fibrosis. Collectively, these findings demonstrate that MUC1 promotes pulmonary fibrosis by binding to and stabilizing HIF-1α, which in turn exacerbates ER stress and mitochondrial dysfunction, leading to AT2 cell apoptosis and necroptosis. Therapeutic inhibition of the MUC1-HIF-1α axis in AT2 cells holds great potential as a novel treatment strategy for IPF.